Main contents starts here

News and Press Releases

January 21, 2003


Dr. Mehmood Khan Joins Takeda Pharmaceuticals North America as Vice President, Medical and Scientific Affairs



LINCOLNSHIRE, IL, January 21, 2003 - Takeda Pharmaceuticals North America, Inc. (TPNA) announced that Mehmood Khan, M.D., F.A.C.E., has joined TPNA as Vice President, Medical & Scientific Affairs, reporting to TPNA's President Mark Booth. In this position, Dr. Khan will be responsible for leading all aspects of TPNA's Medical and Scientific Affairs for ACTOS® (pioglitazone HCl) and future products developed and marketed by the company.

TPNA's Medical and Scientific Affairs department comprises several functions including Medical Affairs, Medical Services, Education and Scientific Affairs, Clinical and Scientific Publications and TPNA's Regional Scientific Managers.

"We are excited to welcome Dr. Khan to Takeda," said Mark Booth, TPNA's president. "With more than 20 years of experience, Dr. Khan brings a tremendous amount of both academic and clinical perspective to TPNA as well as a commitment to patient care. He will be a significant addition to our executive management team and provide great leadership for our Medical and Scientific Affairs department."

Dr. Khan comes to TPNA from the Mayo Clinic in Rochester, Minnesota where he most recently served as Consultant Physician in Endocrinology and Director of the Diabetes, Endocrine and Nutrition Clinical Trials Unit in Mayo's division of endocrinology. He earned his medical degree from the University of Liverpool Medical School, England, and completed a fellowship in clinical endocrinology in the Department of Medicine, University of Minnesota, Minneapolis.

Dr. Khan also has served on numerous state and national committees of the American Diabetes Association, the Minneapolis Medical Research Foundation and the National Institutes of Health. Additionally, he held several visiting professorships, has published extensively and presented at many medical meetings.

Takeda Pharmaceuticals North America, Inc.
Based in Lincolnshire, Ill., Takeda Pharmaceuticals North America, Inc. is a wholly-owned subsidiary of Takeda Chemical Industries, Ltd. in Osaka, Japan. Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the industry's leaders worldwide, Takeda is committed to strive toward better health for individuals and progress in medicine by developing superior pharmaceutical products.

Contacts:

Angela Bechan
Takeda Pharmaceuticals North America, Inc.
847-383-3697
# # #

Page Top